Linklaters advised the EIC Fund (European Innovation Council Fund) on the deal. Created in 2014, XENOTHERA is a French biotech developing a technological platform of glyco-humanized...
Linklaters advised the EIC Fund (European Innovation Council Fund) on the deal. Created in 2014, XENOTHERA is a French biotech developing a technological platform of glyco-humanized...
You must be a Standard 1 Year member to access this content.